Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Patil

Showing results (101-110 of 189) with videos related to

Pageof 19
Sort By:
Ecancermedicalscience|August 3, 2022
Treatment pattern and outcomes in <i>de novo</i> T790M-mutated non-small cell lung cancerGoutam Santosh Panda, Vanita Noronha, Darshit Shah, et al.
Frontiers in Cell and Developmental Biology|November 17, 2022
Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancerIrene A George, Gajanan Sathe, Vivek Ghose, et al.
Journal of Neuro-Oncology|February 20, 2020
Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymomaTejpal Gupta, Madan Maitre, Priyamvada Gupta, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2024
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancerKhushboo A Gandhi, Aditi Shirsat, Sharat Kumar Hj, et al.
Indian Journal of Cancer|August 8, 2018
Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unitTejpal Gupta, Sridhar Epari, Aliasgar Moiyadi, et al.
Neurology India|June 16, 2023
Primary Intracranial Germ Cell Tumors: A Study with an Integrated Clinicopathological ApproachAyushi Sahay, Sridhar Epari, Girish Chinnaswamy, et al.
Ecancermedicalscience|June 10, 2025
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in IndiaMehak Trikha, Vanita Noronha, Minit Shah, et al.
South Asian Journal of Cancer|November 16, 2018
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Ecancermedicalscience|March 1, 2024
Clinical outcomes of <i>ROS1</i>-positive non-small cell lung cancer with limited access to <i>ROS1</i>-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centreGoutam Santosh Panda, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|June 15, 2022
The prevalence of cognitive impairment in older Indian persons with cancer and brain metastasesAditya Dhanawat, Vanita Noronha, Anant Ramaswamy, et al.
Pageof 19

Showing results (101-110 of 189) with videos related to

Sort By:
Pageof 19
Ecancermedicalscience|August 3, 2022
Treatment pattern and outcomes in <i>de novo</i> T790M-mutated non-small cell lung cancerGoutam Santosh Panda, Vanita Noronha, Darshit Shah, et al.
Frontiers in Cell and Developmental Biology|November 17, 2022
Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancerIrene A George, Gajanan Sathe, Vivek Ghose, et al.
Journal of Neuro-Oncology|February 20, 2020
Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymomaTejpal Gupta, Madan Maitre, Priyamvada Gupta, et al.
Cancer Chemotherapy and Pharmacology|July 26, 2024
Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancerKhushboo A Gandhi, Aditi Shirsat, Sharat Kumar Hj, et al.
Indian Journal of Cancer|August 8, 2018
Demographic profile, clinicopathological spectrum, and treatment outcomes of primary central nervous system tumors: Retrospective audit from an academic neuro-oncology unitTejpal Gupta, Sridhar Epari, Aliasgar Moiyadi, et al.
Neurology India|June 16, 2023
Primary Intracranial Germ Cell Tumors: A Study with an Integrated Clinicopathological ApproachAyushi Sahay, Sridhar Epari, Girish Chinnaswamy, et al.
Ecancermedicalscience|June 10, 2025
Clinical characteristics and first-line palliative treatment patterns in 3,414 patients with advanced lung cancer in IndiaMehak Trikha, Vanita Noronha, Minit Shah, et al.
South Asian Journal of Cancer|November 16, 2018
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.
Ecancermedicalscience|March 1, 2024
Clinical outcomes of <i>ROS1</i>-positive non-small cell lung cancer with limited access to <i>ROS1</i>-tyrosine kinase inhibitors (TKIs): experience from an Indian tertiary referral centreGoutam Santosh Panda, Vanita Noronha, Vijay Patil, et al.
Ecancermedicalscience|June 15, 2022
The prevalence of cognitive impairment in older Indian persons with cancer and brain metastasesAditya Dhanawat, Vanita Noronha, Anant Ramaswamy, et al.
Pageof 19